REVS PRO 32 Skin Booster

£52.00

REVs PRO 32 H + L is a stabilized hyaluronic acid (HA) based product intended for skin remodeling and treating skin laxity, not just for filling lines and wrinkles. REVs PRO 32 H + L is to be used in areas affected by skin laxity such as the malar and submalar areas of the face. REVs PRO 32 H + L nourishes the dermal cells and restores the firmness of the skin. REVs PRO 32  H+L improves tissue quality significantly, even in challenging areas, and is complementary to other aesthetic treatments and dermal filler procedures.

The pack consists of:

  • 1 x 2ml syringe (Needles not included)

Benefits of REVs PRO 32

  • Improvement in tissue quality
  • Skin remodelling
  • Treatment of skin laxity
  • Restore skin firmness

How long does the result last for?

Results are instant from the first treatment. In general, results will last from 6 to 9 months and even up to one year depending on individual skin type factors, such as age, and lifestyle.

INJECTION POINTS: 5 point injection each side of the face 0.2ml per injection point.

Only 0 left in stock


The origin of this product is from the European Community (EC)


The origin of this product is from the European Community (EC)

SKU: REVSPRO-32 Categories: , , , Tags: ,
Description

Description

Revs Pro32 is an incredible new 64mg skin booster 32mg high molecular weight HA and 32mg low molecular weight HA.

Ideal for clients wanting strong hydration and biorevitalisation of the dermis! Administered either with 5 point or micro-injections this product is smoother to inject with insane results.

CPNP Registered as a mesotherapy treatment for injection in the superficial dermis.

The pack consists of:

  • 1 x 2ml syringe (Needles not included)

How long does the result last for?

Results are instant from the first treatment. In general, results will last from 6 to 9 months and even up to one year depending on individual skin type factors, such as age, and lifestyle.

INJECTION POINTS: 5 point injection each side of the face 0.2ml per injection point.